These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comparison of the haemodynamic effects of enoximone and piroximone in patients after cardiac surgery. Patel A, Caldicott LD, Skoyles JR, Das P, Sherry KM. Br J Anaesth; 1993 Dec; 71(6):869-72. PubMed ID: 8280556 [Abstract] [Full Text] [Related]
24. Hemodynamic effects of prolonged intravenous therapy with enoximone in patients with severe congestive heart failure. Ferry DR, Kennedy GT, O'Rourke RA, Crawford MH. J Cardiovasc Pharmacol; 1988 Jan; 11(1):115-22. PubMed ID: 2450249 [Abstract] [Full Text] [Related]
25. [Suppression of the adrenal cortex by enoximone. A proband study with documentation of the hemodynamic course]. Sold M, Engelhardt W, Hartung E, Trautner H. Anaesthesist; 1992 Nov; 41(11):680-4. PubMed ID: 1463155 [Abstract] [Full Text] [Related]
26. A study of the combined haemodynamic effects of dobutamine and enoximone in patients taking beta adrenoceptor antagonists. Harvey WR, Monk CR. Anaesth Intensive Care; 1995 Dec; 23(6):673-7. PubMed ID: 8669598 [Abstract] [Full Text] [Related]
27. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone. Schröder T, Hering JP, Foth H, Ferrari M, Sipinková I, Hellige G. Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538 [Abstract] [Full Text] [Related]
28. The effect of glutamate infusion on cardiac performance is independent of changes in metabolism in patients undergoing routine coronary artery bypass surgery. Langenberg CJ, Pietersen HG, Geskes G, Wagenmakers AJ, Lange SD, Schouten HJ, Soeters PB. Clin Sci (Lond); 2001 Dec; 101(6):573-80. PubMed ID: 11724641 [Abstract] [Full Text] [Related]
29. Clinical pharmacology of intravenous enoximone: pharmacodynamics and pharmacokinetics in patients with heart failure. Smith NA, Kates RE, Lebsack C, Ruder MA, Mead RH, Bekele T, Okerholm RA, Rubin GM, Winkle RA. Am Heart J; 1991 Sep; 122(3 Pt 1):755-63. PubMed ID: 1831585 [Abstract] [Full Text] [Related]
30. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group. Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555 [Abstract] [Full Text] [Related]
31. [Hemodynamic effects of new phosphodiesterase inhibitors in patients with coronary heart disease. A comparison between enoximone and R80122]. Kazmaier S, Stephan H, Sonntag H. Anaesthesist; 1995 Jun; 44(6):410-6. PubMed ID: 7653792 [Abstract] [Full Text] [Related]
32. Administration of brain natriuretic peptide improves cardiac function following operations using extracorporeal circulation in an animal model. Bail DH, Steger V, Heinzelmann U, Schiller S, Geim AI, Brüllmann B, Ziemer G. Clin Sci (Lond); 2007 Mar; 112(5):315-24. PubMed ID: 17073825 [Abstract] [Full Text] [Related]
33. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A, European Milrinone Multicenter Trial Group. J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):306-15. PubMed ID: 11426360 [Abstract] [Full Text] [Related]
34. Efficacy of enoximone in the management of refractory low-output states following cardiac surgery. Gonzalez M, Desager JP, Jacquemart JL, Chenu P, Muller T, Installé E. J Cardiothorac Anesth; 1988 Aug; 2(4):409-18. PubMed ID: 17171924 [Abstract] [Full Text] [Related]
35. Effects of preemptive enoximone on left ventricular diastolic function after valve replacement for aortic stenosis. van der Maaten JM, de Vries AJ, Rietman GW, Gallandat Huet RC, De Hert SG. J Cardiothorac Vasc Anesth; 2007 Jun; 21(3):357-66. PubMed ID: 17544886 [Abstract] [Full Text] [Related]
36. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction. Wagner F, Yeter R, Bisson S, Siniawski H, Hetzer R. Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613 [Abstract] [Full Text] [Related]
37. Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial. Caldicott LD, Hawley K, Heppell R, Woodmansey PA, Channer KS. Eur Heart J; 1993 May; 14(5):696-700. PubMed ID: 8508864 [Abstract] [Full Text] [Related]
38. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS. J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566 [Abstract] [Full Text] [Related]
39. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Chrysostomou C, Beerman L, Shiderly D, Berry D, Morell VO, Munoz R. Anesth Analg; 2008 Nov; 107(5):1514-22. PubMed ID: 18931208 [Abstract] [Full Text] [Related]
40. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Tufanogullari B, White PF, Peixoto MP, Kianpour D, Lacour T, Griffin J, Skrivanek G, Macaluso A, Shah M, Provost DA. Anesth Analg; 2008 Jun; 106(6):1741-8. PubMed ID: 18499604 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]